Stay updated on EMPIRE CF: CTX-4430 Clinical Trial
Sign up to get notified when there's something new on the EMPIRE CF: CTX-4430 Clinical Trial page.

Latest updates to the EMPIRE CF: CTX-4430 Clinical Trial page
- CheckyesterdayChange DetectedA site-wide notice was added about a lapse in government funding and the NIH Clinical Center's operation status, including potential delays in updates. The revision tag was updated to v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check8 days agoChange DetectedUI changes include showing the glossary and minor capitalization/label tweaks such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with the addition of 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check43 days agoChange DetectedExpanded list of trial locations across US states and Canada is now displayed, clarifying where the study is conducted.SummaryDifference2%

- Check65 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing the previous Revision: v3.3.1. This appears to be a minor maintenance update with no visible changes to study details or navigation.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.3.1 appears on the page, replacing v3.2.0; this appears to be an internal site version update with no visible changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check79 days agoChange DetectedThe government funding notice/banner was removed from the page, taking away information about potential updates or delays due to funding. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to EMPIRE CF: CTX-4430 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMPIRE CF: CTX-4430 Clinical Trial page.